diabetes-mellitus

Documents about diabetes-mellitus

• Ugandan Non-Communicable Diseases and Aging Cohort#180266ClinicalTrials.gov
• Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D#181712ClinicalTrials.gov
• Insulin Treatment in Diabetic Older People With Heart Failure.#184753ClinicalTrials.gov
• Da Qing Offspring Study#195479ClinicalTrials.gov
• Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes#146407ClinicalTrials.gov
• Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)#67841ClinicalTrials.gov
• PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program#126047ClinicalTrials.gov
• A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.#126064ClinicalTrials.gov
• A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)#127808ClinicalTrials.gov
• Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes#175051ClinicalTrials.gov
• Diagnosis and Management of the Metabolic Syndrome#6886OpenAlex
• The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial#18541ClinicalTrials.gov
• Niveles séricos de colesterol y su relación con cardiopatía isquémica, en pacientes con diabetes mellitus no insulinodependiente#22941Redalyc
• Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects#121255ClinicalTrials.gov
• Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM#121279ClinicalTrials.gov
• The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)#123410ClinicalTrials.gov
• HeAlth-data Register sTudies of Risk and Outcomes in Cardiac Surgery#123632ClinicalTrials.gov
• Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors#143791ClinicalTrials.gov
• Smart Insoles for Improving Sensation, Balance and Mobility in People With Diabetic Peripheral Neuropathy.#148687ClinicalTrials.gov
• Human Immunodeficiency Virus (HIV) Food Insecurities#152613ClinicalTrials.gov
• Early prediction of gestational diabetes mellitus with clinical characteristics, cell-free DNA and genetic variants.#154287NCBI PubMed Central
• Use of Maqui Berry Extract in Treating Oral Candidiasis in Diabetes Mellitus Patients and Systemically Healthy Persons#154701ClinicalTrials.gov
• Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393#154846ClinicalTrials.gov
• The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activation#154866ClinicalTrials.gov
• GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial#172513ClinicalTrials.gov
• Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients#175090ClinicalTrials.gov
• Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment#154808ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before#140961ClinicalTrials.gov
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease#143713ClinicalTrials.gov
• The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.#162361ClinicalTrials.gov
• Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes#195512ClinicalTrials.gov
• Treatment preference for once-weekly versus once-daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials#5184Europe PMC
• A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)#67823ClinicalTrials.gov
• A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients#67837ClinicalTrials.gov
• Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)#123432ClinicalTrials.gov
• Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial#143762ClinicalTrials.gov
• A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy#146372ClinicalTrials.gov
• Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs#158173ClinicalTrials.gov
• A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes#162427ClinicalTrials.gov
• A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults#123406ClinicalTrials.gov
• The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia#141197ClinicalTrials.gov
• Are Audiovisual Materials Superior to Printed Materials in Improving Awareness Among Type 2 Diabetic Patients?#146345ClinicalTrials.gov
• Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects#146382ClinicalTrials.gov
• Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs#152583ClinicalTrials.gov
• Dual task performance in adults with type 2 diabetes mellitus: A systematic review with meta-analysis.#154234NCBI PubMed Central
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition#154894ClinicalTrials.gov
• Nutritional Needs, Dietary Knowledge, and Culinary Skills in Individuals with Diabetes Mellitus: A Scoping Review.#157961NCBI PubMed Central
• "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."#160273ClinicalTrials.gov
• Is Community Based Monitoring of Diabetic Maculopathy and Pre-proliferative Diabetic Retinopathy Safe?#172502ClinicalTrials.gov
• Improving the Diabetic Health of Black Men: MANUP Feasibility Trial#184748ClinicalTrials.gov